Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects

Magnesium Research

Volumn 17, Issue 3, 2004, Pages 189-196

  Rodríguez Morán, Martha ^a,b   Guerrero Romero, Fernando ^a  

^a Gen Hosp Mex Social Secty Inst   (Mexico)

^b NONE   (Mexico)

Author keywords

Inflammation; Insulin resistance; Magnesium; Obesity; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HUMAN; LEAN BODY WEIGHT; MAGNESIUM BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; OBESITY; PROTEIN BLOOD LEVEL;

ADULT; BODY MASS INDEX; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9344271569     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992; 130: 43-52.
2. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995; 270: 23780-4.
3. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543-9.
4. Ishii T, Hirose H, Saito I, Nishikai K, Maruyama H, Saruta T. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism 2000; 49: 1616-8.
5. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119-25.
6. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000; 11: 212-7.
7. Cheung AT, Ree D, Rolls JK, Fuselier J, Coy DH, Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 1998; 139: 4928-35.
8. Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes 2000; 50: 1102-9.
9. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-8.
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.
11. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 2000; 26: 178-82.
12. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 1996; 97: 1111-6.
13. Hube Fm, Hauner H. The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res 1999; 31: 626-31.
14. Malpuech-Brugère C, Nowacki W, Rock E, Gueux E, Mazur A, Rayssiguier Y. Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats an early event during magnesium deficiency. Biochem Biophys Acta 1999; 1453: 35-40.
15. Weglicki WB, Mak IT, Phillips TM, Freedman AM, Cassidy MM, Dickens BF. Magnesium-deficiency elevates circulating of inflammatory cytokines and endothelin. Mol Cell Biochem 1992; 110: 169-73.
16. Rodríguez-Morán M, Guerrero-Romero F. Hyperinsulinemia and abdominal obesity are more prevalent in non-diabetic subjects with family history of Type 2 Diabetes. Arch Med Res 2000; 31: 399-403.
17. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complications 2000; 14: 272-6.
18. Rodriguez-Moran M, Guerrero-Romero F. Oral Magnesium supplementation improves insulin sensitivity and metabolic control in Type 2 diabetic subjects. A randomized, double-blind controlled trial. Diabetes Care 2003; 26: 1147-52.
19. Nilsson J, Jovinge S, Nieman A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998; 18: 199-202.
20. Zietz b, Schäffler A, Büttner R, Schölmerich J, Palitzsch KD. Elevated levels of leptin and insulin but not of TNF alpha are associated with hypertension in type 2 diabetic males. Exp Clin Endocrinol Diabetes 2000; 108: 259-64.
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22 (Suppl. 1): S5-S19.
22. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1987; 157: 2413-46.
23. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis Model Assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
24. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzaneke E, Enrnst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605-19.
25. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumor necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 1999; 163: 33-8.
26. Kellerer M, Rett K, Renn W, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-43.
27. Corica F, Allegra A, Corsonello A, Buerni M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Relat Metab Disord 1999; 23: 355-60.
28. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999; 84: 272-8.
29. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-9.
30. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 119-23.
31. Hauner H, Bender M, Haastert B, Hube F. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 1998; 22: 1239-43.
32. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-4.
33. 2 administration in hypovolemic dogs. Panminerva Med 1999; 41: 323-30.
34. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in mg2 + deficiency by substance P receptor inhibition. Cir Res 1994; 74: 1009-13.
35. Weglicki WB, Mak IT, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992; 263: R764-7.
36. Malpuech-Brugère C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, Lebreton J, Mazur A, Rayssiquier Y. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000; 1501: 91-8.
37. Weglicki WB, Stafford RE, Freedman AM, Cassidy MM, Philips TM. Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model. Am J Physiol 1993; 264: C723-6.
38. Paolisso G, Pizza G, De Riu S, Marrazzo G, Sgambato S, Varricchio M. Impaired insulin-mediated erythrocyte Magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in aged nondiabetic obese patients. Diabetes Metab 1990; 16: 328-33.
39. Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26: 469-74.
40. Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Philips TM. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem 1994; 130: 103-9.
41. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-8.
42. del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 1999; 276: E849-55.
43. Miura A, Ishizuka T, Kanoh Y, Ishizawa M, Itaya S, Kimura M, Kajita K, Yasuda K. Effect of tumor necrosis factor-alpha on insulin signal transduction in rat adipocytes: relation to PKCbeta and zeta translocation. Biochim Biophys Acta 1999; 1449: 227-38.
44. Frittitta L, Youngren JF, Sbraccia P, Adamo M, Buongiorno A, Vigneri R, Goldifine ID, Trischitta V. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997; 40: 282-289 20.
45. Skolnik EY, Marcusohn J. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cyt Gr Fact Rev 1996; 7: 161-73.
46. Paolisso G, Scheen A, D'Onofrio F, Lefèbvre P. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-4.
47. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens 1993; 6: 123S-34S.
48. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans. Am J Hypertens 1999; 12: 747-56.
49. Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in non-diabetic subjects. J Clin Endocrinol Metab 1997; 82: 3783-5.
50. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21: 1024-9.
51. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-92.
52. Pickup JC, Crook MA. Is Type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998; 41: 1241-8.
53. Pickup JC, Chusney GD, Mattock MB. The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction. Clin Endocrinol 2000; 52: 107-12.
54. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM. Role of human skeletal muscle insulin receptor kinase in the vivo insulin resistance of non-insulin-dependent diabetes mellitus and obesity. J Clin Endocrinol & Metab 1994; 78: 471-7.
55. Maegawa H, Shigeta Y, EgawaK, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in non-obese subjects with NIDDM. Diabetes 1991; 40: 815-9.
56. Bulangu L, Nyomba BL, Ossowski VM, Bogardus C, Mott DM. Insulin-sensitive tyrosine kinase:relationship with in vivo insulin action in humans. Am J Physiol 1990; 258: E964-74.
57. Hotamisligil GS, Muray DL, Cho LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-8.
58. Valverde AM, Teruel T, Navarro P, Benito M, Lorenzo M. Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology 1998; 139: 1229-38.
59. Ahmad F, Goldstein BJ. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. J Cell Biochem 1997; 64: 117-27.
60. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C. Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 1999; 892: 119-26.
61. Kellerer M, Mushack J, Mischak H, Häring HU. Protein kinase C (PKC) epsilon enhances the inhibitory effect of TNF alpha on insulin signaling in HEK293 cells. FEBS 1996; Lett 418: 119-22.
62. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271: 665-8.